Results 221 to 230 of about 79,137 (303)

Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background & Aims Endothelial cell (EC) activation is a critical driver of disease progression in cirrhosis, contributing to acute decompensation (AD) and acute‐on‐chronic liver failure (ACLF). Although human albumin administration improves EC function in cirrhotic patients with hypoalbuminemia, its direct effects on ECs remain unclear.
Susan E. Fischer, Rudmer J. Postma, Roel Bijkerk, Annarein J. C. Kerbert, Anton Jan van Zonneveld, Minneke J. Coenraad   +5 more
wiley   +1 more source

Immune Thrombocytopenia and Type 1 von Willebrand Disease in a Patient With a Femoral Fracture: A Case Report. [PDF]

Cureus
Ferreira A, Roberto A.
europepmc   +1 more source

Dried plasma retains hemostatic function and thermal stability during Arctic military operations

Transfusion, Volume 66, Issue S1, Page S159-S171, May 2026.
Abstract Background Dried plasma offers a practical alternative for remote damage control resuscitation, providing hemostatic support and volume replacement. The Arctic presents challenges that necessitate the need for blood‐based resuscitation to extend the “golden hour.” To address this, we evaluated the hemostatic and thermal stability of dried ...
Kanwal Singh, Aron A. Shoara, Henry T. Peng, Viktor Prifti, Katy Moes, Cerys McGuinness, Tristan Bonnici, Maria Shiu, Sushmaa Chandralekha Selvakumar, Peter Andrisani, Pierre‐Marc Dion, Damien Miller, Sebastian Vuong, Colin A. Kretz, Philip J. Wallace, Shawn G. Rhind, Wendy Sullivan‐Kwantes, Andrew N. Beckett   +17 more
wiley   +1 more source

Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study. [PDF]

J Comp Eff Res
Polack B, Nerich V, Micallef CM, Trossaërt M, Biron-Andreani C, Bornier N, Chatelanaz C, Favre-Besse F, Beoletto J, Née M, Belhassen M, Lefèvre C, Pouvourville G.   +12 more
europepmc   +1 more source

Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia

Transfusion, Volume 66, Issue 5, Page 941-951, May 2026.
Abstract Background ABO blood groups may be associated with increased risk for several diseases including cardiovascular diseases (CVDs), particularly coronary heart disease (CHD). The role of other significant blood group systems, such as RhD and RhCE, has not been extensively investigated.
Surendra Karki, Katy Bell, David O. Irving, Marijke Welvaert, Rena Hirani   +4 more
wiley   +1 more source

Characteristics and posttransplant outcomes of patients with congenital and acquired von Willebrand disease and hemophilia A and with renal transplants. [PDF]

Res Pract Thromb Haemost
Chang IW, Truman M, Yee C, Padrnos L.
europepmc   +1 more source

Multiple consecutive daily therapeutic plasma exchange using exclusively albumin replacement fluid in low bleeding risk patients is associated with only rare and mild bleeds

Transfusion, Volume 66, Issue 5, Page 903-909, May 2026.
Abstract Background Therapeutic plasma exchange (TPE) using exclusively albumin replacement fluid depletes coagulation factors, particularly fibrinogen, and concerns about performing multiple consecutive daily procedures due to iatrogenic bleeding exist. Fibrinogen testing to guide bleeding risk stratification is vague.
Jay S. Raval, Joseph R. Griggs, Andres E. Mindiola Romero, Chelsea Reyes, Sarah Mertens, Cynthia Ornelas, Lizabeth Marinaro, Marian A. Rollins‐Raval   +7 more
wiley   +1 more source

Rewriting the script: gene therapy and genome editing for von Willebrand Disease. [PDF]

Front Genome Ed
Barraclough A, Bär I, van Duijl T, Fijnvandraat K, Eikenboom JCJ, Leebeek FWG, Bierings R, Voorberg J, Trasanidou D.   +8 more
europepmc   +1 more source

Type 3 von Willebrand disease in Ethiopia: a comprehensive literature review and report of the first three cases. [PDF]

Thromb J
Arega G, Zewde EB, Said AM, Tesfaye SZ, Tamiru TY, Belisa TK, Ejersa MS, Deress AS.   +7 more
europepmc   +1 more source

Platelet clotting defects in severe trauma identified by a whole blood microfluidic assay

Transfusion, Volume 66, Issue S1, Page S205-S215, May 2026.
Abstract Background Hemorrhage is the leading cause of preventable death in severe trauma, with primary hemostasis relying on platelet‐rich clot formation under high shear flow. This study quantifies the incidence, severity, and heterogeneity of platelet dysfunction in Level I trauma patients.
Gian Rivera Crespo, Jack Killinger, Christopher Bresette, Susan M. Shea, David Ku   +4 more
wiley   +1 more source